Peptide topics
Peptide topic pages are editorial discovery pages. They help users understand where a peptide sits in the directory, which clinics mention it, and which related goals or conditions are commonly associated with it.
Start with the strongest peptide pages
If you are narrowing high-intent treatment options, start with the peptide pages that currently drive the most useful provider comparison and clinic discovery journeys.
Browse by Peptide
Find clinic listings associated with specific peptide topics.
BPC-157
BPC-157 is a research peptide studied mostly in animal models for tissue and gut repair. See what the evidence and 2026 UK & US legal status actually say, and what to ask clinics that reference it.
Explore
TB-500
TB-500 is a research peptide studied mostly in animal models for tissue repair. See what the evidence and 2026 legal status say, why it's banned in sport, and what to ask clinics that reference it.
Explore
Semaglutide
Compare clinics and online programs offering semaglutide for medically supervised weight management. Verified providers, transparent pricing, US & UK.
Explore
Tirzepatide
Browse clinics and online programs referencing tirzepatide for supervised weight management. Compare prescribers, pricing, and clinical oversight standards.
Explore
Liraglutide
Compare clinics referencing liraglutide in weight-management and metabolic-health contexts. Verified provider listings with clinical supervision details.
Explore
Retatrutide
Retatrutide ('reta') is Eli Lilly's investigational triple-agonist for weight management — Phase 3 results are strong, but it is not approved anywhere yet. See what the trials show, why online 'reta' is grey market, and what the legitimate routes are.
Explore
CJC-1295
CJC-1295 is a synthetic GHRH analogue often paired with ipamorelin. See what the evidence and 2026 legal status say, why it's WADA-banned in sport, and what to ask clinics that reference it.
Explore
Ipamorelin
Ipamorelin is a growth-hormone secretagogue, often paired with CJC-1295. What the evidence and 2026 legal status say, why it's WADA-banned in sport, and what to ask clinics that reference it.
Explore
Tesamorelin
Find clinics referencing tesamorelin in hormone optimisation and metabolic protocols. Compare verified providers, prescribing context, and clinical supervision.
Explore
HGH
Browse clinics that discuss HGH and growth-hormone optimisation. Understand how providers position GH therapy, screening, and supervision before booking.
Explore
GHK-Cu
GHK-Cu is the copper peptide widely used in anti-aging skincare. How topical cosmetic use differs from unapproved injectable use, what the evidence says, and what to ask clinics that reference it.
Explore
Epitalon
Understand how clinics reference epitalon within longevity research and anti-aging contexts. Compare provider positioning and supervision standards.
Explore
NAD+
NAD+ is a coenzyme offered in clinics as an IV infusion for energy and healthy-aging. See what the evidence actually supports, how it's given, what it typically costs, and what to ask before booking.
Explore
NMN
Understand how longevity clinics reference NMN — a NAD+ precursor — within healthy-aging protocols. Compare provider context and supervision standards.
Explore
PT-141
PT-141 (bremelanotide) is a sexual-desire peptide, FDA-approved as Vyleesi for one specific use. How it differs from the research-peptide version, what the evidence says, and what to ask clinics.
Explore
Sermorelin
Sermorelin is a GHRH peptide once FDA-approved as Geref, now compounded. What the evidence and its regulatory history say, why it's WADA-banned in sport, and what to ask clinics that reference it.
Explore
MK-677
MK-677 (ibutamoren) is an oral growth-hormone secretagogue, not a true peptide. See what the evidence and 2026 legal status say, why it's banned in sport, and what to ask clinics that reference it.
Explore
DSIP
Understand how clinics reference DSIP in sleep, recovery, and stress-modulation contexts. Compare provider positioning and research standing.
Explore
Semax
Semax is a Russian-developed nootropic peptide — a registered medicine in Russia since 1994, but unapproved in the US and UK. See what the evidence actually shows, its 2026 regulatory position, and what to ask providers who mention it.
Explore
MOTS-c
MOTS-c is a mitochondrial-derived peptide with intense longevity interest — no completed human trials of the peptide itself, and explicitly WADA-banned since 2024. See what the evidence and status actually are.
Explore
AOD-9604
AOD-9604 is an hGH-fragment peptide with real Phase 2 human trial history — and a development programme that stopped anyway. Understand its unusual US compounding position and its WADA ban.
Explore
Thymosin Alpha-1
Thymosin alpha-1 (Zadaxin) is an immune peptide approved in 35+ countries — but not the US or UK. See what it's actually approved for, its shifting 2026 US compounding status, and why it should not be confused with TB-500.
Explore
Selank
Selank is a Russian-developed anxiolytic peptide — registered as a medicine in Russia, but unapproved in the US and UK. Understand the evidence base, the regulatory reality, and the questions worth asking.
Explore
Cagrilintide
Cagrilintide is Novo Nordisk's amylin analogue, best known as half of CagriSema — the semaglutide combination now under FDA review. See the real trial results, the approval timeline, and why online 'cagrilintide' is grey market.
Explore
Survodutide
Survodutide is Boehringer Ingelheim's glucagon/GLP-1 dual agonist — strong Phase 3 obesity results and breakthrough status in liver disease, but not approved anywhere yet. Understand the evidence and the timeline.
Explore
SS-31 (Elamipretide)
SS-31 (elamipretide) is the first mitochondria-targeted drug ever FDA-approved — but only for a rare disease called Barth syndrome. The longevity uses sold online are a different story. See what's approved and what isn't.
Explore
5-Amino-1MQ
5-Amino-1MQ is an NNMT-inhibitor 'fat-loss' compound with striking mouse data and zero human trials — and it isn't actually a peptide. See what the evidence really shows before anyone sells it to you.
Explore
KPV
KPV is a three-amino-acid fragment of alpha-MSH studied for gut and skin inflammation — promising rodent data, no completed human trials, and a US compounding status that moved in 2026. Here's the real picture.
Explore
Snap-8
Snap-8 (acetyl octapeptide-3) is a topical cosmetic peptide marketed as 'Botox-like' — legal in skincare, with manufacturer-funded evidence and real delivery limitations. Injecting it is a different matter entirely.
Explore